Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros

Medicinas Complementárias
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Mol Neurobiol ; 58(8): 3665-3676, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33797061

RESUMEN

We examined the neuropharmacological effects of ethanol extract of Ficus erecta Thunb leaves (EEFE) on cognitive dysfunction in a scopolamine (SCO)-induced memory impairment animal model. Memory impairment was measured using the Y-maze test and passive avoidance task (PAT). For 19 days, EEFE (100 or 200 mg/kg) was treated through oral administration. Treatment with EEFE ameliorated memory impairment in behavioral tests, along with significant protection from neuronal oxidative stress and neuronal cell loss in the brain tissues of SCO-injected mice. Antioxidant and neuroprotective effects of EEFE were further confirmed using in vitro assays. Our findings indicate that the mechanisms of neuroprotection and antioxidation of EEFE are regulated by the cholinergic system, promotion of cAMP response element-binding protein (CREB) phosphorylation, and the nuclear factor erythroid-2-related factor 2 (Nrf2)/heme oxygenase (HO)-1 signaling activation. The current study proposes that EEFE could be an encouraging plant resource and serve as a potent neuropharmacological drug candidate against neurodegenerative diseases.


Asunto(s)
Neuronas Colinérgicas/efectos de los fármacos , Ficus , Trastornos de la Memoria/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/uso terapéutico , Escopolamina/toxicidad , Animales , Línea Celular , Antagonistas Colinérgicos/toxicidad , Neuronas Colinérgicas/metabolismo , Relación Dosis-Respuesta a Droga , Masculino , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/metabolismo , Ratones , Ratones Endogámicos ICR , Estrés Oxidativo/fisiología , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Hojas de la Planta
2.
Toxicon ; 177: 52-88, 2020 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-32217234

RESUMEN

Datura stramonium, Atropa belladonna, Hyoscyamus niger, and Scopolia carniolica are all temperate plants from the family Solanaceae, which as a result of their anticholinergic tropane alkaloids, hyoscyamine/atropine and scopolamine, have caused many cases of poisoning around the world. Despite the danger these nightshade plants represent, the literature often presents incomplete cases lacking in details and filled with ambiguity, and reviews on the topic tend to be limited in scope. Many also point to a gap in knowledge of these plants among physicians. To address this, the following review focuses on intoxications involving these plants as reported in the literature between 1966 and 2018, with brief mention to pertinent related plants to contextualise and provide a fuller picture of the situation surrounding the presently discussed temperate plants. Analysis of the literature displays that D. stramonium is largely associated with drug use among teens while A. belladonna is primarily ingested as a result of the berries being mistaken for edible fruits. H. niger was found to be largely ingested when mistaken for other plants, and S. carniolica was the cause of incredibly few intoxications.


Asunto(s)
Antagonistas Colinérgicos/toxicidad , Extractos Vegetales/toxicidad , Intoxicación por Plantas/epidemiología , Solanaceae , Alcaloides Solanáceos/toxicidad , Alcaloides , Atropa belladonna , Europa (Continente) , Humanos , Hyoscyamus , Escopolamina , Scopolia , Tropanos
3.
Cent Nerv Syst Agents Med Chem ; 19(2): 125-132, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30836928

RESUMEN

OBJECTIVE: The present study was designed to investigate the potential of Pistacia vera (P. vera) fruits in experimental memory impairments in mice. MATERIAL & METHODS: Memory impairment was induced in Swiss Albino mice by scopolamine (0.4mg mg/kg. i.p). Animals were divided into five separate groups of six animals each, positive control group received carboxy methyl cellulose (CMC) as vehicle, negative control group received scopolamine with vehicle, and standard group received donepezil (5mg/kg i.p) with Scopolamine. Ethanolic extract of P. vera (EEPV) at doses of 200mg/kg & 400mg/kg p.o were administered to group test1 & test 2 respectively along with scopolamine. Elevated plus maze (EPM), passive avoidance paradigms and morris water maze (MWM) were used as exteroceptive behavioral models to access learning and memory activity. Transfer latency, step down latency and escape latency parameters were evaluated plus maze, passive avoidance paradigm, morris water maze. Thereafter lipid peroxidation test, glutathione level and catalase activities were estimated in homogenized brain of mice. RESULTS: Pretreatment of mice with EEPV (200mg/kg & 400mg/kg) significantly reduced scopolamine induced amnesia. The obtained data clearly revealed that there was increase in escape latency in MWM and also increase in step down latency in passive avoidance paradigm. Transfer latencey was found to be decrease in EPM and biochemical. Parameters were clearly satisfied the data as compared to negative control group which was indicative of cognitive improvement. CONCLUSION: P. vera fruit extract demonstrated to improve cognitive process by enhancing memory in different experimental paradigm such as EPM, passive avoidance and MWM when administered orally. Hence it would be worthwhile to explore the potential of this plant in the management of memory disorders.


Asunto(s)
Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/tratamiento farmacológico , Memoria/efectos de los fármacos , Pistacia , Extractos Vegetales/farmacología , Escopolamina/toxicidad , Animales , Antagonistas Colinérgicos/toxicidad , Relación Dosis-Respuesta a Droga , Femenino , Frutas , Masculino , Aprendizaje por Laberinto/fisiología , Memoria/fisiología , Trastornos de la Memoria/inducido químicamente , Ratones , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/uso terapéutico
4.
Biomed Pharmacother ; 111: 496-502, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30594789

RESUMEN

Certain biflavonoids have been proven to protect against cognitive dysfunction. A new biflavonoid, CGY-1, isolated from Cardiocrinum giganteum seeds, has not yet been reported to have any neuroprotective effect. In this study, a scopolamine-induced memory deficit model was used to explore the neuroprotective effect of CGY-1. Behavioral experiments, such as tests using the Morris water maze, the Y-maze and the fear conditioning test, were conducted. The results revealed that oral administration of CGY-1 (20 and 40 mg/kg) and donepezil shortened the escape latency, improved the percentage of spontaneous alternation, and increased the freezing times, respectively. CGY-1 decreased the levels of reactive oxygen species and malondialdehyde and increased the activities of superoxide dismutase and glutathione peroxidase in the hippocampus. In addition, CGY-1 decreased the activity of acetylcholinesterase and increased the activities of choline acetyltransferase and acetylcholine in the hippocampus. Furthermore, qPCR and western blot results revealed that the expressions of neurotrophic factors, brain-derived neurotrophic factor and nerve growth factor were upregulated in the hippocampus after CGY-1 treatment. In conclusion, CGY-1 could be a promising candidate for the treatment of cognitive dysfunction.


Asunto(s)
Biflavonoides/uso terapéutico , Neuronas Colinérgicas/efectos de los fármacos , Medicamentos Herbarios Chinos/uso terapéutico , Lilium , Trastornos de la Memoria/tratamiento farmacológico , Escopolamina/toxicidad , Animales , Biflavonoides/aislamiento & purificación , Biflavonoides/farmacología , Antagonistas Colinérgicos/toxicidad , Neuronas Colinérgicas/metabolismo , Medicamentos Herbarios Chinos/aislamiento & purificación , Medicamentos Herbarios Chinos/farmacología , Masculino , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/metabolismo , Ratones , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Semillas
5.
Int J Mol Sci ; 19(2)2018 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-29370115

RESUMEN

Though Oldenlandia diffusa Herba (ODH) has been known to exhibit anti-cancer and anti-inflammatory effects, its anti-amnestic effect has never been reported so far. The aim of this present study was to elucidate the anti-amnestic effect of ODH. ODH pretreatment significantly reduced escape latency of scopolamine treated Institute of Cancer Research (ICR) mice compared to untreated control groups in a Morris water maze test. Similarly, the passive avoidance test showed that ODH treatment recovered the scopolamine induced amnesia in the ICR mouse model. Concentration of Ach in brains of ODH treated mice was increased compared to that of scopolamine treated mice. In addition, activity of acetylcholinesterase (AChE) was notably decreased by ODH. The protein expression of brain-derived neurotrophic factor (BDNF) and phospho-cAMP response element-binding protein (p-CREB) (Ser133) was increased in ODH pretreated group compared to control group. Consistently, immunohistochemistry (IHC) revealed the elevated expression of brain-derived neurotrophic factor (BDNF) and p-CREB in brains of ODH treated mice compared to the control group. Overall, these findings suggest that ODH has anti-amnestic potential via activation of BDNF and p-CREB and inhibition of AChE in mice with scopolamine induced amnesia.


Asunto(s)
Inhibidores de la Colinesterasa/farmacología , Disfunción Cognitiva/tratamiento farmacológico , Fármacos Neuroprotectores/farmacología , Oldenlandia/química , Extractos Vegetales/farmacología , Acetilcolina/metabolismo , Acetilcolinesterasa/metabolismo , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Antagonistas Colinérgicos/toxicidad , Inhibidores de la Colinesterasa/uso terapéutico , Disfunción Cognitiva/etiología , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Fármacos Neuroprotectores/uso terapéutico , Extractos Vegetales/uso terapéutico , Escopolamina/toxicidad
7.
J Ethnopharmacol ; 193: 474-480, 2016 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-27693774

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Seeds of Sisymbrium irio Linn has been used traditionally in different regions of Pakistan for the treatment of gastrointestinal, airways and vascular system ailments. To insight the pharmacological basis, in vitro study was conducted in order to validate its folkloric uses. MATERIAL AND METHODS: 70% aqueous-methanolic extract of seeds from S. irio (Si.MEs) was tested on isolated rabbit aorta, jejunum and trachea strip hanged in tissue bath having physiological solutions aerated with carbogen and their responses were measured and recorded via Power Lab. RESULTS: The Si.MEs exhibited the transient spasmogenic effect (0.01-1.0mg/mL) on spontaneous jejunum contractions, followed by the spasmolytic effect. The addition of atropine resulted in blocking in spasmogenic effect while the spasmolytic effect was originated, suggesting the presence of an antimuscarinic effect. Likewise verapamil, Si.MEs (0.03-5mg/mL) repressed the high concentration K+(80mM)-induced contraction and also drifted the Ca2+ concentration-response curves toward right (0.3-3.0mg/mL), possibly signifying the Ca2+ channel blockade. Furthermore, Si.MEs exhibited nonspecific relaxant effect on carbachol (1µM)- and high concentration K+(80mM)-induced tracheal contractions in a way comparable to dicyclomine, suggesting the coexistence of Ca2+-antagonistic and/or antimuscarinic properties. Additionally, Si.MEs also relaxed the phenylephrine(1µM)- and high concentration K+(80mM)-induced aortic contraction (0.01-3mg/mL), suggesting blockade of Ca2+ channel. Moreover, oral administration of Si.MEs, as high as 6g per kg, did not produce lethality among the treated groups of mice. CONCLUSIONS: Aqueous-methanolic extract of seeds from S. irio (Si.MEs) exhibited the bronchodilator and gut modulator (spasmogenic and spasmolytic) activities, probably through dual blockade of muscarinic receptors and Ca2+ channels, whereas, vasodilator effect may be due to Ca2+ channels blockade.


Asunto(s)
Aorta/efectos de los fármacos , Brassicaceae/química , Bloqueadores de los Canales de Calcio/farmacología , Antagonistas Colinérgicos/farmacología , Folclore , Yeyuno/efectos de los fármacos , Extractos Vegetales/farmacología , Tráquea/efectos de los fármacos , Animales , Broncodilatadores/aislamiento & purificación , Broncodilatadores/farmacología , Bloqueadores de los Canales de Calcio/aislamiento & purificación , Bloqueadores de los Canales de Calcio/toxicidad , Antagonistas Colinérgicos/aislamiento & purificación , Antagonistas Colinérgicos/toxicidad , Relación Dosis-Respuesta a Droga , Etnobotánica , Etnofarmacología , Femenino , Fármacos Gastrointestinales/aislamiento & purificación , Fármacos Gastrointestinales/farmacología , Motilidad Gastrointestinal/efectos de los fármacos , Técnicas In Vitro , Masculino , Metanol/química , Ratones , Contracción Muscular/efectos de los fármacos , Fitoterapia , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/toxicidad , Plantas Medicinales , Conejos , Semillas/química , Solventes/química , Vasoconstricción/efectos de los fármacos , Vasodilatadores/aislamiento & purificación , Vasodilatadores/farmacología
8.
J Ethnopharmacol ; 193: 107-116, 2016 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-27492328

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: G. rigescens Franch (Long Dan Cao in Chinese) is a well-known TCM herb. It is clinically used with other drugs for the treatment of brain diseases such as epilepsy, postherpetic neuralgia in China. AIM OF STUDY: In our previous study, the 11 dihydroxybenzoates compounds with NGF mimicking activity from G. rigescens Franch were found. In the present study, the neurogenesis and neuroprotection of a mixture of benzoates ( n-GS) were investigated in animal level. MATERIALS AND METHODS: The NGF mimicking activity of n-GS from G. rigescens Franch was examined in PC12 cells. The neurogenesis effects of n-GS were investigated in ICR mice with 5-bromo-2-deoxyuridine (BrdU) and neuronal neclei (NeuN) double immunostaining. Furthermore, the neuroprotection effects of n-GS on the memory in a scopolamine (SCO)-induced mouse model were evaluated with animal behavior tests. RESULTS: The NGF-mimicking function and neurogenesis of n-GS were observed in PC12 cells and in normal mice. Subsequently, we investigated the effects of n-GS on the memory in a SCO-induced mouse model. In Y-maze test, SCO significantly lowered the alternation. This finding was reversed by n-GS and donepezil (DONE). SCO significantly impaired the mice's performance in novel object recognition (NOR) and Morris water maze (MWM) tests. The time spent to explore the novel object was longer in the n-GS- and DONE-treated groups than in the SCO control group. In the MWM test, the escape latency of n-GS- and DONE-treated groups was shorter than that of the SCO control group. Mechanism study showed that SCO significantly reduced superoxide dismutase (SOD) but increased the activities of acetylcholinesterase (AChE) and the levels of malondialdehyde (MDA) in the hippocampus and cerebral cortex, which all can be improved by n-GS and DONE. Additionally, the phosphorylation of type 1 insulin-like growth factor (IGF-1) receptor, extracellular signal-regulated kinase (ERK), and cAMP responsive element-binding (CREB) protein in the hippocampus was significantly up-regulated in the treatment group compared with that in the SCO group. CONCLUSIONS: n-GS could alleviate impaired memory of the SCO-induced mice model by inhibiting AChE activity and oxidative stress, and regulating the IGF-1R/ERK signaling pathway.


Asunto(s)
Gentiana/química , Trastornos de la Memoria/tratamiento farmacológico , Preparaciones de Plantas/farmacología , Animales , Benzoatos , Antagonistas Colinérgicos/toxicidad , Trastornos de la Memoria/inducido químicamente , Ratones , Ratones Endogámicos ICR , Escopolamina/toxicidad
9.
Nutr Neurosci ; 19(3): 125-30, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-25216329

RESUMEN

Gumiganghwal-tang (GT) is a traditional herbal medicine that is widely used for its anti-inflammatory, analgesic, and antipyretic actions. Fermented GT has been reported to inhibit acetylcholinesterase (AChE) activity and to exert a neuroprotective effect. In this study, we investigated the effect of fermented GT against scopolamine-induced memory impairment in mice using the Morris water maze and passive avoidance tests. The results of the Morris water maze test indicated that fermented GT significantly decreased escape latency, as compared with that observed in the scopolamine-treated group. In the prove test, fermented GT attenuated the decreased time spent in the target quadrant observed after scopolamine treatment. The results of the passive avoidance test indicated that the treatment with fermented GT increased latency time when compared with the scopolamine-treated group. Moreover, fermented GT inhibited AChE activity in the hippocampi of the treated mice. These results suggest that fermented GT reduced scopolamine-induced amnesia in mice through AChE inhibition. Therefore, we hypothesize that fermented GT may be a useful therapeutic agent for the prevention or treatment of neurodegenerative diseases.


Asunto(s)
Inhibidores de la Colinesterasa/uso terapéutico , Suplementos Dietéticos , Modelos Animales de Enfermedad , Trastornos de la Memoria/prevención & control , Nootrópicos/uso terapéutico , Extractos Vegetales/uso terapéutico , Acetilcolinesterasa/metabolismo , Animales , Reacción de Prevención/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Antagonistas Colinérgicos/toxicidad , Inhibidores de la Colinesterasa/administración & dosificación , Donepezilo , Fermentación , Proteínas Ligadas a GPI/antagonistas & inhibidores , Proteínas Ligadas a GPI/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/enzimología , Indanos/uso terapéutico , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/enzimología , Ratones Endogámicos ICR , Antagonistas Muscarínicos/toxicidad , Proteínas del Tejido Nervioso/antagonistas & inhibidores , Proteínas del Tejido Nervioso/metabolismo , Neuronas/efectos de los fármacos , Neuronas/enzimología , Nootrópicos/administración & dosificación , Piperidinas/uso terapéutico , Extractos Vegetales/administración & dosificación , República de Corea , Escopolamina/toxicidad
10.
Neurol Sci ; 36(4): 553-60, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25367404

RESUMEN

Alzheimer's disease (AD) is a progressive neurological disorder that mostly affects the elderly population. Learning and memory impairment as the most characteristic manifestation of dementia could be induced chemically by scopolamine, a cholinergic antagonist. Cholinergic neurotransmission mediated brain oxidative stress. Citrus aurantium (CA) has traditionally been used for the treatment of insomnia, anxiety and epilepsy. The present study was designed to investigate the effect of Citrus aurantium on scopolamine-induced learning and memory deficit in rats. Forty-two Wistar rats were divided into six equal groups. (1) Control (received saline), (2) SCOP (scopolamine at a dose of 1 mg/kg for 15 days), (3) and (4) SCOP + CA (scopolamine and CA extract at doses of 300 and 600 mg/kg per day for 15 days), (5) and (6) intact groups (CA extract at 300 and 600 mg/kg per day for 15 days, respectively). Administration of CA flower extract significantly restored memory and learning impairments induced by scopolamine in the passive avoidance test and also reduced escape latency during trial sessions in the Morris water maze test. Citrus aurantium flower extract significantly decreased the serum malondialdehyde (MDA) levels. Citrus aurantium flower extract has repairing effects on memory and behavioral disorders produced by scopolamine and may have beneficial effects in the treatment of AD.


Asunto(s)
Citrus , Flores/química , Trastornos de la Memoria/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Acetilcolinesterasa , Análisis de Varianza , Animales , Antioxidantes/metabolismo , Reacción de Prevención/efectos de los fármacos , Encéfalo/metabolismo , Antagonistas Colinérgicos/toxicidad , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Compuestos Férricos/sangre , Masculino , Malondialdehído/metabolismo , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/patología , Ratas , Tiempo de Reacción/efectos de los fármacos , Escopolamina/toxicidad , Aprendizaje Espacial/efectos de los fármacos
11.
Indian J Exp Biol ; 50(10): 690-5, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23214261

RESUMEN

Present study involves evaluation of effects of 75% ethanolic extract of seabuckthorn [Hippophae rhamnoides L. (SBT)] leaves on scopolamine induced cognitive impairment in rats using three different oral doses i.e. 50, 100 and 200 mg/kg body weight through assessment of various biochemical and behavioural parameters. Scopolamine administration resulted in an increase in acetylcholinesterase (AChE) activity (approximately 9% with respect to the control group) and malonaldehyde (MDA) content. The increased AChE activity was significantly reduced in animals receiving 200 and 100 mg/kg of SBT extract. Animals treated with SBT extract showed significantly reduced MDA level in all the doses. This reduction in MDA content indicates that SBT leaf extract has potent antioxidant activities and exhibits a protective effect against oxidative damage induced by scopolamine. Behavioural studies also indicated significant improvement. The results suggest that SBT leaf extract has potential effects against scopolamine induced cognitive impairment by regulating cholinergic marker enzyme activity (AChE activity) and promoting the antioxidant system and may be explored for its use in cognitive disorders.


Asunto(s)
Conducta Animal/efectos de los fármacos , Trastornos del Conocimiento/tratamiento farmacológico , Hippophae/química , Fitoterapia , Extractos Vegetales/uso terapéutico , Hojas de la Planta/química , Escopolamina/toxicidad , Acetilcolinesterasa/metabolismo , Animales , Antioxidantes/uso terapéutico , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Antagonistas Colinérgicos/toxicidad , Trastornos del Conocimiento/inducido químicamente , Trastornos del Conocimiento/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Oxidación-Reducción , Ratas , Ratas Sprague-Dawley
12.
Arch Pharm Res ; 33(10): 1685-90, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21052945

RESUMEN

In this study, the effect of daidzin or daidzein isolated from Pueraria lobata on the memory impairments induced by scopolamine was assessed in male mice using the passive avoidance and the Morris water maze tasks. Administration of daidzin (5 mg/kg) or daidzein (5 mg/kg) significantly reversed the scopolamine (1 mg/kg)-induced cognitive impairments in male mice as evidenced by the passive avoidance test (p < 0.05) and on the Morris water maze test (p < 0.05). Moreover, the ameliorating effects of daidzin or daidzein were antagonized by tamoxifen (1 mg/kg), the nonspecific estrogen receptor antagonist. These results indicate that daidzin or daidzein may be useful in cognitive impairment induced by cholinergic dysfunction, and this beneficial effect is mediated, in part, via estrogen receptor.


Asunto(s)
Antagonistas Colinérgicos/toxicidad , Isoflavonas/uso terapéutico , Discapacidades para el Aprendizaje/prevención & control , Trastornos de la Memoria/prevención & control , Fitoestrógenos/uso terapéutico , Escopolamina/toxicidad , Animales , Reacción de Prevención/efectos de los fármacos , Antagonistas de Estrógenos/farmacología , Glucósidos/antagonistas & inhibidores , Glucósidos/uso terapéutico , Isoflavonas/antagonistas & inhibidores , Discapacidades para el Aprendizaje/inducido químicamente , Discapacidades para el Aprendizaje/metabolismo , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/metabolismo , Ratones , Ratones Endogámicos ICR , Fitoestrógenos/antagonistas & inhibidores , Receptores de Estrógenos/agonistas , Receptores de Estrógenos/antagonistas & inhibidores , Receptores de Estrógenos/metabolismo , Natación , Tamoxifeno/farmacología
13.
J Pharm Pharmacol ; 62(2): 263-71, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20487207

RESUMEN

OBJECTIVES: The ameliorating effects of wild ginseng on learning and memory deficits were investigated in rats. METHODS: Rats were treated daily with wild ginseng or cultivated ginseng for 7 days at 30 min before scopolamine injection (2 mg/kg, i.p.). After inducing cognitive impairment by the administration of scopolamine, behavioural assessment using the Morris water maze was performed. Changes in cholinergic system reactivity were also examined by measuring the immunoreactive neurons of choline acetyltransferase and the reactivity of acetylcholinesterase in the hippocampus. KEY FINDINGS: Scopolamine injection induced impaired performance in the water maze test and severe cell losses in hippocampal cholinergic neurons, as indicated by decreased choline acetyltransferase immunoreactivity and increased acetylcholinesterase reactivity. Daily administration of wild ginseng produced a significant improvement in the escape latency for finding the platform in the Morris water maze and reduced the loss of cholinergic immunoreactivity in the hippocampus. The reduced expression of brain-derived neurotrophic factor mRNA due to the scopolamine injection was recovered to normal levels by the administration of wild ginseng. CONCLUSIONS: Wild ginseng demonstrates a significant neuroprotective effect against scopolamine-induced neuronal and cognitive impairment.


Asunto(s)
Acetilcolina/antagonistas & inhibidores , Antagonistas Colinérgicos/toxicidad , Hipocampo/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Panax/química , Extractos Vegetales/farmacología , Escopolamina/toxicidad , Acetilcolinesterasa/metabolismo , Animales , Factor Neurotrófico Derivado del Encéfalo/biosíntesis , Recuento de Células , Colina O-Acetiltransferasa/metabolismo , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Hipocampo/enzimología , Hipocampo/metabolismo , Hipocampo/patología , Inmunohistoquímica , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/efectos de los fármacos , Neuronas/efectos de los fármacos , Neuronas/enzimología , Neuronas/metabolismo , Neuronas/patología , Fármacos Neuroprotectores/aislamiento & purificación , Panax/crecimiento & desarrollo , Extractos Vegetales/aislamiento & purificación , Raíces de Plantas/química , Raíces de Plantas/crecimiento & desarrollo , ARN Mensajero/biosíntesis , Ratas , Ratas Sprague-Dawley , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
14.
Pharmacol Res ; 55(5): 450-4, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17368042

RESUMEN

PURPOSE: The objective was to validate an in vivo model for evaluation of pharmacological effects on bladder function taking the most predominant anticholinergic side effect (hyposalivation) into account. Therefore, two anticholinergic properties (propiverine hydrochloride and tolterodine-L(+)-tartrate) were used to test the in vivo model. Sacral anterior root stimulation (SARS) was performed to induce reproducible and standardized bladder contractions. To evaluate hyposalivation standardised salivavary flow measurements by stimulating the lingual nerve was performed in addition to SARS. MATERIALS AND METHODS: 10 male mini pigs were anaesthetised. The carotid artery was cannulated for blood pressure measurement and the jugular vein for administration of propiverine 0.4 mg kg(-1) b.w. and tolterodine 0.06 mg kg(-1) b.w. For stimulation-induced salivary flow measurements both lingual nerves were exposed and a cuff electrode was placed around the nerves. The bladder was exposed and a cystostomy catheter was inserted to performed cystometrographic measurements during SARS. RESULTS: In all experiments, for each animal reproducible intravesical pressure values (pves) and salivary flow rates were elicited during electrostimulation before administration of the drug. Bladder pressure: After administration of propiverine, neurostimulation-induced rise in pves had fallen by 60% from the initial value. After administration of tolterodine pves had fallen by about 50%. After additional administration of atropine pves decreased to about 15% of the initial value for both drugs. Salivation: After propiverine salivary flow had fallen by 61%. Inhibition of salivary flow under tolterodine was about 56%. Additional administration of atropine led in both drugs to a nearly complete blockade of salivation. Heart rate (HR) and blood pressure (BP): Directly following intravenous administration of both drugs, a short-term and reversible period of mild but significant fluctuations in HR was observed. There was also a slight but non-significant rise in blood pressure. CONCLUSIONS: This model allows comparative investigations of various drugs with bladder inhibitory properties in terms of acute efficacy and side effects.


Asunto(s)
Antagonistas Colinérgicos/farmacología , Evaluación Preclínica de Medicamentos/normas , Contracción Muscular/efectos de los fármacos , Glándulas Salivales/efectos de los fármacos , Salivación/efectos de los fármacos , Porcinos Enanos , Vejiga Urinaria/efectos de los fármacos , Xerostomía/inducido químicamente , Animales , Atropina/farmacología , Compuestos de Bencidrilo/farmacología , Bencilatos/farmacología , Presión Sanguínea/efectos de los fármacos , Antagonistas Colinérgicos/toxicidad , Cresoles/farmacología , Evaluación Preclínica de Medicamentos/métodos , Estimulación Eléctrica , Frecuencia Cardíaca/efectos de los fármacos , Nervio Lingual , Masculino , Modelos Animales , Fenilpropanolamina/farmacología , Reproducibilidad de los Resultados , Glándulas Salivales/inervación , Glándulas Salivales/fisiopatología , Porcinos , Tartrato de Tolterodina , Vejiga Urinaria/inervación , Xerostomía/fisiopatología
15.
Xenobiotica ; 31(8-9): 633-50, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11569530

RESUMEN

1. Torsades de pointes (TDP) is a potentially fatal ventricular tachycardia associated with increases in QT interval and monophasic action potential duration (MAPD). TDP is a side-effect that has led to withdrawal of several drugs from the market (e.g. terfenadine and terodiline). 2. The potential of compounds to cause TDP was evaluated by monitoring their effects on MAPD in dog. Four compounds known to increase QT interval and cause TDP were investigated: terfenadine, terodiline, cisapride and E4031. On the basis that only free drug in the systemic circulation will elicit a pharmacological response target, free concentrations in plasma were selected to mimic the free drug exposures in man. Infusion regimens were designed that rapidly achieved and maintained target-free concentrations of these drugs in plasma and data on the relationship between free concentration and changes in MAPD were obtained for these compounds. 3. These data indicate that the free ED50 in plasma for terfenadine (1.9 nM), terodiline (76 nM), cisapride (11 nM) and E4031 (1.9 nM) closely correlate with the free concentration in man causing QT effects. For compounds that have shown TDP in the clinic (terfenadine, terodiline, cisapride) there is little differentiation between the dog ED50 and the efficacious free plasma concentrations in man (< 10-fold) reflecting their limited safety margins. These data underline the need to maximize the therapeutic ratio with respect to TDP in potential development candidates and the importance of using free drug concentrations in pharmacokinetic/pharmacodynamic studies.


Asunto(s)
Butilaminas/toxicidad , Cisaprida/toxicidad , Piperidinas/toxicidad , Piridinas/toxicidad , Terfenadina/toxicidad , Torsades de Pointes/inducido químicamente , Potenciales de Acción/efectos de los fármacos , Animales , Antiarrítmicos/farmacocinética , Antiarrítmicos/farmacología , Antiarrítmicos/toxicidad , Proteínas Sanguíneas/metabolismo , Butilaminas/farmacocinética , Butilaminas/farmacología , Bloqueadores de los Canales de Calcio/farmacocinética , Bloqueadores de los Canales de Calcio/farmacología , Bloqueadores de los Canales de Calcio/toxicidad , Antagonistas Colinérgicos/farmacocinética , Antagonistas Colinérgicos/farmacología , Antagonistas Colinérgicos/toxicidad , Cisaprida/farmacocinética , Cisaprida/farmacología , Perros , Evaluación Preclínica de Medicamentos , Fármacos Gastrointestinales/farmacocinética , Fármacos Gastrointestinales/farmacología , Fármacos Gastrointestinales/toxicidad , Antagonistas de los Receptores Histamínicos H1/farmacocinética , Antagonistas de los Receptores Histamínicos H1/farmacología , Antagonistas de los Receptores Histamínicos H1/toxicidad , Humanos , Masculino , Piperidinas/farmacocinética , Piperidinas/farmacología , Unión Proteica , Piridinas/farmacocinética , Piridinas/farmacología , Seguridad , Terfenadina/farmacocinética , Terfenadina/farmacología , Torsades de Pointes/fisiopatología
16.
Rev. argent. anestesiol ; 59(1): 32-9, ene.-feb. 2001. tab, graf
Artículo en Español | LILACS | ID: lil-288446

RESUMEN

El Síndrome Neuroléptico Maligno es una enfermedad rara pero con alta mortalidad, por lo cual es conveniente tenerla presente ante la aparición de un cuadro de hipertermia inducido por drogas. En ocasiones la presentación clínica suele ser indistinguible de una Hipertermia Maligna, si bien su mecanismo fisiopatológico es completamente diferente. Sus características clínicas comprenden hipertermia, rigidez muscular, elevación de la creatininfosfoquinasa (C.P.K.) además de mioglobinemia y mioglobinuria, como consecuencia de la rabdomiólisis. En esta recopilación mencionaremos su fisiopatología, etiología, criterios clínicos, su relación con Hipertermia maligna y los detalles de su tratamiento.


Asunto(s)
Humanos , Diagnóstico Diferencial , Antagonistas de Dopamina/efectos adversos , Hipertermia Inducida/efectos adversos , Hipertermia Inducida/mortalidad , Recurrencia , Síndrome Neuroléptico Maligno/etiología , Síndrome Neuroléptico Maligno/fisiopatología , Síndrome Neuroléptico Maligno/terapia , Antipsicóticos , Antipsicóticos/efectos adversos , Antagonistas Colinérgicos/toxicidad , Catatonia/diagnóstico , Catatonia/mortalidad , Dantroleno/uso terapéutico , Encefalitis Viral/diagnóstico , Rigidez Muscular/etiología , Factores de Riesgo , Síndrome de la Serotonina/congénito
17.
Rev. argent. anestesiol ; 59(1): 32-9, ene.-feb. 2001. tab, graf
Artículo en Español | BINACIS | ID: bin-10179

RESUMEN

El Síndrome Neuroléptico Maligno es una enfermedad rara pero con alta mortalidad, por lo cual es conveniente tenerla presente ante la aparición de un cuadro de hipertermia inducido por drogas. En ocasiones la presentación clínica suele ser indistinguible de una Hipertermia Maligna, si bien su mecanismo fisiopatológico es completamente diferente. Sus características clínicas comprenden hipertermia, rigidez muscular, elevación de la creatininfosfoquinasa (C.P.K.) además de mioglobinemia y mioglobinuria, como consecuencia de la rabdomiólisis. En esta recopilación mencionaremos su fisiopatología, etiología, criterios clínicos, su relación con Hipertermia maligna y los detalles de su tratamiento. (AU)


Asunto(s)
Humanos , Síndrome Neuroléptico Maligno/etiología , Síndrome Neuroléptico Maligno/fisiopatología , Síndrome Neuroléptico Maligno/terapia , Hipertermia Inducida/efectos adversos , Hipertermia Inducida/mortalidad , Antagonistas de Dopamina/efectos adversos , Diagnóstico Diferencial , Recurrencia , Rigidez Muscular/etiología , Dantroleno/uso terapéutico , Antipsicóticos , Antipsicóticos/efectos adversos , Factores de Riesgo , Catatonia/diagnóstico , Catatonia/mortalidad , Síndrome de la Serotonina/congénito , Encefalitis Viral/diagnóstico , Antagonistas Colinérgicos/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA